Isoniazid
- PDF / 169,097 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 34 Downloads / 169 Views
1 S
Hepatitis: case report In a retrospective review (IRB-105066-E) of patients, who underwent latent tuberculosis infection (LTBI) screening between January 2013 and April 2014, a patient [age and sex not stated] was described, who developed hepatitis while receiving isoniazid for prophylaxis for Mycobacterium tuberculosis (MTB). The patient who underwent LTBI screen showed positivity for interferon-gamma release assay (IGRA) tests. Consequently, the patient was treated with isoniazid 900 mg/day for 9 months [route not stated] as a prophylactic for MTB. However, the patient developed hepatitis secondary to isoniazid [time to reaction onset and outcome not stated]. Wang P-H, et al. Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients. BMC Pulmonary 803519616 Medicine 20: 31 Aug 2020. Available from: URL: http://doi.org/10.1186/s12890-020-01274-9
0114-9954/20/1833-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 5 Dec 2020 No. 1833
Data Loading...
